Assistant Professor at the Department of Anesthesiology and Intensive Care, Faculty of Medicine, Tanta University, Egypt. ORCID: https://orcid.org/0000-0001-8804-6959.
Lecturer at the Department of Anesthesiology and Intensive Care, Faculty of Medicine, Tanta University, Egypt.
J Opioid Manag. 2022 Jan-Feb;18(1):47-56. doi: 10.5055/jom.2022.0694.
This study aimed to evaluate the ability to use opioid-free anesthesia (OFA) technique in morbid obese patients.
A prospective randomized double-blinded study.
This study was carried out at Tanta University Hospitals (tertiary hospitals).
Eighty morbid obese patients scheduled for laparoscopic bariatric surgeries.
Patients were allocated randomly into two groups: Group C, in which fentanyl was used during induction and maintenance of anesthesia, and group OFA, in which dexmedetomidine, ketamine, magnesium, and lidocaine were started before the induction of anesthesia and continued throughout the surgery.
The post-operative morphine consumption in the first 24 hours (primary outcome) and the intraoperative fentanyl consumption (secondary outcome).
In comparison to the control group, OFA technique significantly decreased the post-operative morphine consumption (p = 0.003; 95 percent CI: 0.505; 2.396), shortened the time for the first request of rescue analgesia (p < 0.0001; 95 percent CI: 54.14; 99.11), decreased the post-operative pain score 4 and 6 hours after surgery (p < 0.05), and decreased the post-operative nausea and vomiting (PONV) impact scale (p = 0.022). Furthermore, it significantly decreased the intraoperative fentanyl consumption (p < 0.0001) with the improvement of all parameters of the recovery profile (p < 0.05).
OFA in patients undergoing bariatric surgeries significantly decreased the post-operative morphine consumption, the post-operative pain score, the intraoperative fentanyl consumption, and the PONV impact scale with the improvement of the recovery profile.
本研究旨在评估在病态肥胖患者中使用无阿片麻醉(OFA)技术的能力。
前瞻性随机双盲研究。
本研究在坦塔大学医院(三级医院)进行。
拟行腹腔镜减重手术的 80 例病态肥胖患者。
患者随机分为两组:C 组,诱导和维持麻醉时使用芬太尼;OFA 组,在麻醉诱导前开始使用右美托咪定、氯胺酮、镁和利多卡因,并在整个手术过程中持续使用。
术后 24 小时内吗啡消耗量(主要结局)和术中芬太尼消耗量(次要结局)。
与对照组相比,OFA 技术显著降低了术后吗啡消耗量(p=0.003;95%置信区间:0.505;2.396),缩短了首次请求解救镇痛的时间(p<0.0001;95%置信区间:54.14;99.11),降低了术后 4 小时和 6 小时的疼痛评分(p<0.05),并降低了术后恶心呕吐(PONV)影响评分(p=0.022)。此外,它显著降低了术中芬太尼的消耗(p<0.0001),同时改善了所有复苏特征参数(p<0.05)。
在接受减重手术的患者中,OFA 显著降低了术后吗啡消耗量、术后疼痛评分、术中芬太尼消耗量和 PONV 影响评分,同时改善了复苏特征。